FDA Approved: LIALDA — Original Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approval of LIALDA (mesalamine) under Takeda Pharmaceuticals America's original NDA for the treatment of ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• LIALDA (mesalamine)

Snippet

ORIG AP for LIALDA (MESALAMINE)